Last Updated on December 2, 2024 by The Health Master
CDSCO Panel
A Major Breakthrough in Cancer Treatment: Intas Pharmaceuticals has recently received a significant approval from the CDSCO Panel i.e. Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market the anti-cancer drug Pertuzumab.
This approval is a major step forward in the fight against HER2-positive metastatic breast cancer.
Understanding Pertuzumab
Pertuzumab is a monoclonal antibody, a type of protein that targets specific cells. In the case of HER2-positive breast cancer, Pertuzumab works by targeting the HER2 protein, which can lead to uncontrolled cell growth.
By inhibiting the HER2 protein, Pertuzumab can help slow down or stop the growth of cancer cells.
Key Points about the Approval from CDSCO Panel:
- Conditional Approval: The CDSCO Panel approval is subject to the condition that Intas Pharmaceuticals conducts Phase IV clinical trials in India.
- Phase IV Trial Requirement: The company must submit the protocol for the Phase IV trial within three months of receiving marketing authorization.
- Indication: The drug is approved for the treatment of HER2-positive metastatic breast cancer.
What Does This Mean for Patients?
This CDSCO panel approval brings hope to patients with HER2-positive metastatic breast cancer.
Pertuzumab, when used in combination with other treatments, has shown promising results in improving patient outcomes.
However, it’s important to consult with a healthcare professional to determine if Pertuzumab is the right treatment option for you.
The Future of Cancer Treatment
The CDSCO panel approval of Pertuzumab by Intas Pharmaceuticals is a significant milestone in the field of oncology.
It highlights the growing focus on targeted therapies and personalized medicine.
As research continues to advance, we can expect to see more innovative treatments emerging to improve the lives of cancer patients.
-
What is HER2-positive breast cancer?
HER2-positive breast cancer is a type of breast cancer that has too much of a protein called HER2. This excess HER2 protein can cause cancer cells to grow and divide more quickly.
-
How does Pertuzumab work?
Pertuzumab targets the HER2 protein and blocks its ability to signal other cells. This helps to slow down or stop the growth of cancer cells.
-
What are the potential side effects of Pertuzumab?
Common side effects of Pertuzumab include fatigue, diarrhea, and rash. More serious side effects are less common but can occur. It’s important to discuss potential side effects with your healthcare provider.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
CDSCO approval granted for Anti Cancer Drug Olaparib
CDSCO Panel nod granted for Lumateperone Capsule
CDSCO Recruitment Rules for Medical Device Officers: A Closer Look
CDSCO Panel nod for Clinical Trial of Ranibizumab Solution for Injection
CDSCO Nod granted to Conduct Clinical Trial of Ruxolitinib cream
CDSCO Gains Global Recognition: Milestone for Indian Medical Device Industry
India drops Anti Dumping probe on Mono Ethylene Glycol
Kerala Drug Control Department Goes Digital: A New Era of Efficiency
NPPA’s ceiling price for Methylprednisolone Upheld
Hospital caught overcharging for Medicines: Hyderabad
Standards for 214 Critical Medical Devices to be developed
FDA Maharashtra cracks down on 15 Medical Stores
Ceiling Price for Acyclovir 800 mg Tablets upheld
Strengthening drug security through Pharmaceutical Supply Chain
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
